RecruitingNot ApplicableNCT05711485

Platelet-Directed Whole Blood Transfusion Strategy for Malaria

Clinical and Translational Investigations of Severe Malaria Pathophysiology [Parent Study Protocol]

Sponsor

Johns Hopkins Bloomberg School of Public Health

Enrollment

132 participants

Start Date

Feb 24, 2024

Study Type

INTERVENTIONAL

Conditions

Thrombocytopenia Severe Malaria

Summary

Open-label randomized controlled trial to test the effectiveness of whole blood transfusion for improving survival in children with severe malaria complicated by thrombocytopenia.

Eligibility

Min Age: 6 MonthsMax Age: 59 Months

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Whole blood transfusion for people with severe malaria and thrombocytopenia. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 6 Months to 59 Months.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.